Research & Analysis
ACP-105 Half-Life: What the Evidence Actually Shows
Only two half-life figures for ACP-105 trace to a documented source: an in vitro human hepatocyte value of 5.0 hours and a separate 2025 computational model predicting about 1.18 hours; no human pharmacokinetic study has measured the compound's half-life directly, and other figures circulating online (4-6 hours, 6 hours, 12-16 hours) do not trace to any identifiable primary source.
SARMS Institute Research Desk. Compiled from primary sources. Last updated 20 July 2026.
This page is for education and does not provide medical or legal advice. No SARM is approved for human use.
This page is for education and does not provide medical or legal advice. No SARM is approved for human use.